Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
PLUS Corporation has invested in and entered into a capital and business…
ND Software has introduced a new paid feature for its AI voice…
Curatis Holding AG has signed an exclusive licensing and development agreement with…
CMIC Co., Ltd., a contract research organization jointly owned by Blackstone and…
The healthcare sector in Japan is evolving at a brisk pace with…
Science Aid has started working with Tecan Japan on a project that…
Fujitsu Limited and DT Axis Corporation have entered into a partnership to…
Japanese healthtech company Dr.JOY Inc. is rolling out a new Hospital DX…
Sign in to your account